Diseases & Disorders
(G96C)
AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$3.8M
Total Revenue
$3.2M
Total Expenses
$20.3M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
84.6%
Fundraising Efficiency
0.0%
Operating Reserve
76.44x
Liability-to-Asset
2.4%
Revenue Diversification
52.3%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $3.8M | $3.2M | $20.3M | 84.6% | 0 |
| 2022 | $3.9M | $2.8M | N/A | — | 0 |
| 2021 | $3.0M | $1.4M | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.